Education
About Us
Working with TipRanks
Follow Us
Gerresheimer AG (GB:0NTI)
:0NTI
0NTI Stock Chart & Stats
Day’s Range― - ―
52-Week Range€63.10 - €111.00
Previous CloseN/A
Volume180.18K
Average Volume (3M)46.59K
Market Cap
€2.76B
Enterprise Value€4.75B
Total Cash (Recent Filing)€106.50M
Total Debt (Recent Filing)€1.12B
Price to Earnings (P/E)24.9
Beta0.22
Next Earnings
Apr 11, 2025EPS Estimate
0.59Next Dividend Ex-Date
Jun 06, 2025Dividend Yield1.53%
Share Statistics
EPS (TTM)3.18
Shares Outstanding34,540,000
10 Day Avg. Volume39,894
30 Day Avg. Volume46,590
Financial Highlights & Ratios
PEG Ratio45.30
Price to Book (P/B)N/A
Price to Sales (P/S)1.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€103.57Price Target Upside27.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Primary Packaging Glass PerformancePrimary Packaging Glass showed 15% sequential quarter-on-quarter growth, leading to a beat at EBITDA driven by a stronger 4Q margin.
Bears Say
Organic Growth And GuidanceOrganic FY24 growth came in below the updated guide, led by a disappointing P&D end of year.
Plastics & Devices Segment PerformancePlastics & Devices segment numbers came in below expectations, disappointing given this segment is considered the core growth vertical.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
13.31% Mutual Funds
0.40% Other Institutional Investors
77.59% Public Companies and
Individual Investors
0NTI FAQ
What was Gerresheimer AG’s price range in the past 12 months?
Gerresheimer AG lowest share price was €63.10 and its highest was €111.00 in the past 12 months.
What is Gerresheimer AG’s market cap?
Gerresheimer AG’s market cap is €2.76B.
When is Gerresheimer AG’s upcoming earnings report date?
Gerresheimer AG’s upcoming earnings report date is Apr 11, 2025 which is in 33 days.
How were Gerresheimer AG’s earnings last quarter?
Gerresheimer AG released its earnings results on Feb 26, 2025. The company reported €1.63 earnings per share for the quarter, beating the consensus estimate of €1.385 by €0.245.
Is Gerresheimer AG overvalued?
According to Wall Street analysts Gerresheimer AG’s price is currently Undervalued.
Does Gerresheimer AG pay dividends?
Gerresheimer AG pays a Annually dividend of €1.25 which represents an annual dividend yield of 1.53%. See more information on Gerresheimer AG dividends here
What is Gerresheimer AG’s EPS estimate?
Gerresheimer AG’s EPS estimate is 0.59.
How many shares outstanding does Gerresheimer AG have?
Gerresheimer AG has 34,540,000 shares outstanding.
What happened to Gerresheimer AG’s price movement after its last earnings report?
Gerresheimer AG reported an EPS of €1.63 in its last earnings report, beating expectations of €1.385. Following the earnings report the stock price went down -0.697%.
Which hedge fund is a major shareholder of Gerresheimer AG?
Currently, no hedge funds are holding shares in GB:0NTI
---
Gerresheimer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€103.57 (27.77% Upside)
€103.57 (27.77% Upside)
Insider Transactions
Bought Shares
Worth €75.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.79%
12-Months-Change
Fundamentals
Return on Equity
7.42%
Trailing 12-Months
Asset Growth
11.13%
Trailing 12-Months
Company Description
Gerresheimer AG
Gerresheimer AG provides specialty glass and plastic products to the pharmaceutical and healthcare industry. The firm operates in three segments: plastics and devices, primary packaging glass and advanced technologies. The plastics and devices segment sells products for drug administration, including insulin pens, inhalers, prefillable syringes, and plastic packaging for medications. The primary packaging glass segment produces glass packaging products for drugs and cosmetics, such as injection vials, cartridges, and jars. The advanced technologies segment develops and manufactures intelligent drug delivery systems. Gerresheimer generates the majority of its revenue in Europe, with sales in Germany contributing the largest proportion of any country.
---
0NTI Stock 12 Month Forecast
Average Price Target
€103.57
▲(27.77% Upside)
Technical Analysis
Best Analysts Covering 0NTI
1 Year
1 Year Success Rate
10/17 ratings generated profit
1 Year Average Return
+10.28%
upgraded a buy rating 24 days ago
Copying Sven Olaf Kuerten's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +10.28% per trade.
---